Abstract
Objective: – To compare minimally invasive (MIPD) and open (OPD) pancreatoduodenectomy in different subtypes of ampullary adenocarcinoma (AAC). Background: – AAC is widely seen as the best indication for MIPD due to the lack of vascular involvement and dilated bile and pancreatic duct. However, it is unknown whether outcomes of MIPD for AAC differ between the pancreatobiliary (AAC-PB) and intestinal (AAC-IT) subtypes as large studies are lacking. Methods: – This is an international cohort study, encompassing 27 centers from 12 countries. Outcomes of MIPD and OPD were compared in patients with AAC-IT and AAC-PB. Primary endpoints were R1 rate, lymph node yield, and 5-year overall survival. Results: – Overall, 1187 patients after MIPD for AAC were included, of whom 572 with AAC-IT (62 MIPD and 510 OPD) and 615 with AAC-PB (41 MIPD and 574 OPD). The rate of R1 resection was not significantly different between MIPD and OPD for both AAC-IT (3.4% vs 6.9%, P = 0.425) and AAC-PB (9.8% vs 14.9%, P = 0.625). AAC-IT, more lymph nodes were resected with the MIPD group (19 vs 16, P = 0.007), compared with OPD. The 5-year overall survival did not differ after MIPD and OPD for both AAC-IT (56.8% vs 59.5%, P = 0.827 and AAC-PB (52.5% vs 44.4%, P = 0.357). The rates of surgical complications between MIPD and OPD did not differ between AAC-IT and AAC-PB. Conclusions: – This international multicenter study found no differences in outcomes between MIPD and OPD for AAC-IT and AAC-PB. MIPD and OPD demonstrated comparable outcomes in oncological resection, survival and surgical outcomes for both subtypes of AAC.
| Original language | English |
|---|---|
| Journal | Annals of Surgery |
| Volume | 283 |
| Issue number | 5 |
| Pages (from-to) | 848-854 |
| Number of pages | 7 |
| ISSN | 0003-4932 |
| DOIs | |
| Publication status | Published - 05.2026 |
Funding
Conflicts of interests : Mario Serradilla-Martín received research funding from Baxter S.L.. Patrick Pessaux is co-founder of Virtualisurg; Geert Kazemier is Chairman of the Advisory Board of Renovaro Inc.; Marc G. Besselink has received grants from Intuitive for the LEARNBOT European robot Whipple training program, the DIPLOMA-2 trial, and the E-MIPS quality registry, from Medtronic for the investigator-initiated DIPLOMA trial and from Ethicon for the PANDORA trial and the E-MIPS quality registry; Mohammed Abu Hilal received funding from Associazione Italiana per la Ricerca sul Cancro (AIRC); All remaining authors claim no conflicts of interests and no disclosures.
| Funders | Funder number |
|---|---|
| Medtronic | |
| Associazione Italiana per la Ricerca sul Cancro |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Outcome of Minimally Invasive and Open Pancreatoduodenectomy in Patients With Intestinal and Pancreatobiliary Subtype Ampullary Cancer: An International Multicenter Cohort Study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver